CHANNEL BY TOPICS

QUICK LINKS

Dotmatics Informatics Selected to Enhance Collaborative Research at Moulder Center for Drug Discovery

BISHOPS STORTFORD, England --(Business Wire)--

Dotmatics
Limited, a leading provider of informatics solutions to the
pharmaceutical and biotechnology industries, today announced that The
Moulder Centre for Drug Discovery Research at Temple University have
licensed Dotmatics' suite of solutions to boost their drug discovery
research efforts.

The Dotmatics platform is an integrated suite of software specifically
designed to maximise efficiency in data transfer between research
institutes, collaborators and CROs.

"After a thorough review of the commercially available software packages
for sharing and exploiting the fruits of drug discovery research, it
became clear that the Dotmatics platform represented not only the best
configuration, but also the most comprehensive package available" said
Dr. Magid Abou-Gharbia, Associate Dean for Research and Director of the
Moulder Center. "In building our capacity at the Moulder Center for Drug
Discovery Research we are focused on efficiently generating research
data using a host of technologies and tools. The combination of Browser,
Vortex
and StudiesNotebook
are key solutions which will allow our scientists to quickly triage,
integrate and analyze data from multiple sources, speeding the pace and
efficiency of research. These advantages afford our scientists increased
opportunity to improve the health of patients through the discovery of
new therapeutic agents."

The migration of The Moulder Center for Drug Discovery Research's legacy
database to the Dotmatics platform will have a positive and dramatic
impact on research workflow. Dr. Abou-Gharbia continued "Researchers at
our center will benefit from the advanced data querying, analysis and
reporting tools provided by this high end informatics platform. In
addition, the secure web-based deployment of Dotmatics software will
allow our external collaborators to easily access their data while
maintaining safeguards against the release of data from unrelated
programs. Our adoption of the Dotmatics system provides The Moulder
Center with cutting edge Cheminformatics and database capabilities."

About Dotmatics

At the forefront of innovation, Dotmatics is a leading global scientific
informatics software and services provider, delivering solutions
tailored to the modern, highly collaborative and mobile pharmaceutical,
biotechnology, chemical industries and academia. Dotmatics' enterprise
solutions are flexible, scalable and configurable, providing effective
scientific information management across entire organizations, from
discovery research to development to early manufacturing. The web-based
knowledge solutions dramatically improve the way scientific data is
queried, managed and shared within and across organizations. Dotmatics
has significant expertise in scientific informatics, including database
management for chemistry and biologics, screening data management, SAR
analysis, reporting, and visualization. A privately owned company,
Dotmatics was founded in 2005 and is headquartered in the UK.

About The Moulder Center

The Moulder Center for Drug Discovery Research was
established in 2008 as a multidisciplinary drug discovery research hub
in Philadelphia's Temple University School of Pharmacy. Equipped with
unique capabilities and experienced scientists/researchers, the Center
is actively pursuing collaborative research opportunities
within Temple University and with external collaborators in the academic
community, as well as industrial partners both in the U.S. and abroad.
The Moulder Center is unique in that it is the only fully integrated
academic drug discovery center focusing on a wide range of diseases and
disorders. The Center is led by its founding director, Dr. Magid
Abou-Gharbi, who has over 26 years of pharmaceutical industry experience
as Senior Vice President of Discovery Research at Wyeth Pharmaceutical.
On the web at http://moulder.temple.edu/.